Highlighted Text:
Show |
Hide
Full text loading...
Chapter 10 : Closed Due to Rabies
Authors:
Jesse D. Blanton1,
John W. Krebs2
VIEW AFFILIATIONS
HIDE AFFILIATIONS
Affiliations:
1: Poxvirus and Rabies Branch, National Center for Zoonotic, Vector-Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333;
2: Rickettsial Zoonosis Branch, National Center for Zoonotic, Vector-Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333
Content Type: Trade
Publication Year:
2009
Category: General Interest
Book DOI:
10.1128/9781555815950
Chapter DOI:
10.1128/9781555815950.ch10
MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
Preview this chapter:
Closed Due to Rabies, Page 1 of 2
< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555815950/9781555814847_Chap10-1.gif /docserver/preview/fulltext/10.1128/9781555815950/9781555814847_Chap10-2.gif
Abstract:
In most areas of the world where the disease is endemic, dogs and other carnivores remain the common sources of human rabies virus infection, resulting in little change over time in the epidemiology of the disease. Routine public health activities consisting of animal rabies control, health communication and education, and preexposure prophylaxis and postexposure prophylaxis (PEP) will remain the most cost-effective methods for preventing human rabies. The most effective way to prevent exposure to rabies is to educate the public to avoid contact with all wild and unfamiliar domestic animals. Each year in the United States, as many as 40,000 persons receive rabies PEP and perhaps as many as 20,000 receive preexposure vaccination. The importance of immediate and thorough washing of all bite wounds and scratches with soap and water cannot be overemphasized, since it may, in itself, be one of the most effective measures for preventing rabies; tetanus prophylaxis and measures to control bacterial infection should be given as necessary. The regimen for preexposure vaccination consists of three 1.0-ml doses (0.5 ml for purified Vero cell rabies vaccine) given i.m. in the deltoid area on days 0, 7, and 21 or 28. Americans planning to travel to or reside in countries where canine rabies is enzootic should be informed about the risk of rabies and consider the possible benefits of rabies preexposure vaccination.
Citation:
Blanton J, Krebs J.
2009.
Closed Due to Rabies,
p 251-273.
In
Schlossberg D (ed),
Infections of Leisure, Fourth Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815950.ch10
Key Concept Ranking
- Lagos bat virus
- 0.4850007
- Zoonotic Diseases
- 0.40987316
- Rabies virus
- 0.40670797
0.4850007
Figures
Closed Due to Rabies
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815950.ch10-1,webId=/content/author/10.1128/9781555815950.ch10-1,properties={foaf_givenname=Jesse D., foaf_name=Jesse D. Blanton, foaf_surname=Blanton, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815950.ch10-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815950.ch10-2,webId=/content/author/10.1128/9781555815950.ch10-2,properties={foaf_givenname=John W., foaf_name=John W. Krebs, foaf_surname=Krebs, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815950.ch10-aff2]]}]]
Citation:
Blanton J, Krebs J.
2009.
Closed Due to Rabies,
p 251-273.
In
Schlossberg D (ed),
Infections of Leisure, Fourth Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815950.ch10
/content/10.1128/9781555815950.ch10.ch10fig01
FIGURE 1
Average annual numbers of cases of terrestrial rabies in the United States, 2003 to 2007.
10.1128/9781555815950/ch10fig1_thmb.gif
10.1128/9781555815950/ch10fig1.gif
FIGURE 1
Average annual numbers of cases of terrestrial rabies in the United States, 2003 to 2007.
Citation:
Blanton J, Krebs J.
2009.
Closed Due to Rabies,
p 251-273.
In
Schlossberg D (ed),
Infections of Leisure, Fourth Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815950.ch10
/content/10.1128/9781555815950.ch10.ch10fig02
FIGURE 2
Average annual numbers of cases of bat rabies in the United States, 2003 to 2007.
10.1128/9781555815950/ch10fig2_thmb.gif
10.1128/9781555815950/ch10fig2.gif
FIGURE 2
Average annual numbers of cases of bat rabies in the United States, 2003 to 2007.
Citation:
Blanton J, Krebs J.
2009.
Closed Due to Rabies,
p 251-273.
In
Schlossberg D (ed),
Infections of Leisure, Fourth Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815950.ch10
/content/10.1128/9781555815950.ch10.ch10fig03
FIGURE 3
Distribution of terrestrial rabies virus variants and associated reservoirs in the United States, 2007.
10.1128/9781555815950/ch10fig3_thmb.gif
10.1128/9781555815950/ch10fig3.gif
FIGURE 3
Distribution of terrestrial rabies virus variants and associated reservoirs in the United States, 2007.
Citation:
Blanton J, Krebs J.
2009.
Closed Due to Rabies,
p 251-273.
In
Schlossberg D (ed),
Infections of Leisure, Fourth Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815950.ch10
/content/10.1128/9781555815950.ch10.ch10fig04
FIGURE 4
Spatiotemporal distribution of raccoon rabies in North America.
10.1128/9781555815950/ch10fig4_thmb.gif
10.1128/9781555815950/ch10fig4.gif
FIGURE 4
Spatiotemporal distribution of raccoon rabies in North America.
Citation:
Blanton J, Krebs J.
2009.
Closed Due to Rabies,
p 251-273.
In
Schlossberg D (ed),
Infections of Leisure, Fourth Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815950.ch10
/content/10.1128/9781555815950.ch10.ch10fig05
FIGURE 5
Brain biopsy showing Negri bodies, cellular inclusions found most frequently in the pyramidal cells of Ammon’s horn and the Purkinje cells of the cerebellum. They are also found in the cells of the medulla and various other ganglia. In addition to the presence of these characteristic histopathologic changes, direct fluorescent antibody testing establishes a specific diagnosis of rabies. Source: CDC/Daniel P. Perl (http://phil.cdc.gov/phil/quicksearch.asp).
10.1128/9781555815950/ch10fig5_thmb.gif
10.1128/9781555815950/ch10fig5.gif
FIGURE 5
Brain biopsy showing Negri bodies, cellular inclusions found most frequently in the pyramidal cells of Ammon’s horn and the Purkinje cells of the cerebellum. They are also found in the cells of the medulla and various other ganglia. In addition to the presence of these characteristic histopathologic changes, direct fluorescent antibody testing establishes a specific diagnosis of rabies. Source: CDC/Daniel P. Perl (http://phil.cdc.gov/phil/quicksearch.asp).
Citation:
Blanton J, Krebs J.
2009.
Closed Due to Rabies,
p 251-273.
In
Schlossberg D (ed),
Infections of Leisure, Fourth Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815950.ch10
References
/content/book/10.1128/9781555815950.ch10
1.
Afshar, A. 1979. A review of non-bite transmission of rabies virus infection. Br. Vet. J. 135: 142– 148.
2.
Anderson, L. J.,, K. G. Nicholson,, R. V. Tauxe, and, W. G. Winkler. 1984. Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention. Ann. Intern. Med. 100: 728– 735.
3.
Anderson, L. J.,, R. K. Sikes,, C. W. Langkop,, J. M. Mann,, J. S. Smith,, W. G. Winkler, and, M. W. Deitch. 1980. Postexposure trial of a human diploid cell strain rabies vaccine. J. Infect. Dis. 142: 133– 138.
4.
Bell, G. R. 1967. Death from rabies in a ten-year-old boy (one of two cases in United States in 1966). S. D. J. Med. 20: 28– 29.
5.
Bernard, K. W., and, D. B. Fishbein. 1991. Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost? Vaccine 9: 833– 836.
6.
Blanton, J. D.,, N. Y. Bowden,, M. Eidson,, J. D. Wyatt, and, C. A. Hanlon. 2005. Rabies postexposure prophylaxis, New York, 1995–2000. Emerg. Infect. Dis. 11: 1921– 1927.
7.
Blanton, J. D.,, C. A. Hanlon, and, C. E. Rupprecht. 2007. Rabies surveillance in the United States during 2006. J. Am. Vet. Med. Assoc. 231: 540– 556.
8.
Blanton, J. D.,, A. Meadows,, S. M. Murphy,, J. Manangan,, C. A. Hanlon,, M. L. Faber,, B. Dietzschold, and, C. E. Rupprecht. 2006. Vaccination of small Asian mongoose (Herpestes javanicus) against rabies. J. Wildl. Dis. 42: 663– 666.
9.
Blanton, J. D.,, D. Palmer,, K. Christian, and, C. E. Rupprecht. 2008. Rabies surveillance in the United States during 2007. J. Am. Vet. Med. Assoc. 233: 884– 897.
10.
Blanton, J. D., and, C. E. Rupprecht. 2008. Travel vaccination for rabies. Expert. Rev. Vaccines 7: 613– 620.
11.
Bogel, K., and, E. Motschwiller. 1986. Incidence of rabies and post-exposure treatment in developing countries. Bull. W. H. O. 64: 883– 887.
12.
Briggs, D. J. 2007. Human rabies vaccines, p. 505–515. In A. C. Jackson and, W. H. Wunner (ed.), Rabies, 2nd ed. Academic Press, London, United Kingdom.
13.
Briggs, D. J., and, K. Schweitzer. 2001. Importation of dogs and cats to rabies-free areas of the world. Vet. Clin. N. Am. Small Anim. Pract. 31: 573– 583, viii.
14.
Castrodale, L.,, V. Walker,, J. Baldwin,, C. Hofmann, and, C. Hanlon. 2008. Rabies in a puppy imported from India to the USA, March 2007. Zoonoses Public Health 55: 427– 430.
15.
CDC. 2008. Compendium of animal rabies prevention and control, 2008: National Association of State Public Health Veterinarians, Inc. (NASPHV). MMWR Recommend. Rep. 57: 1– 9.
16.
CDC. 2003. First human death associated with raccoon rabies—Virginia, 2003. MMWR Morb. Mortal. Wkly. Rep. 52: 1102– 1103.
17.
CDC. 1995. Human rabies—Alabama, Tennessee, and Texas, 1994. MMWR Morb. Mortal. Wkly. Rep. 44: 269– 272.
18.
CDC. 1988. Human rabies—California, 1987. MMWR Morb. Mortal. Wkly. Rep. 37: 305– 308.
19.
CDC. 1992. Human rabies—California, 1992. MMWR Morb. Mortal. Wkly. Rep. 41: 461– 463.
20.
CDC. 1994. Human rabies—California, 1994. MMWR Morb. Mortal. Wkly. Rep. 43: 455– 458.
21.
CDC. 1996. Human rabies—California, 1995. MMWR Morb. Mortal. Wkly. Rep. 45: 353– 356.
22.
CDC. 2002. Human rabies—California, 2002. MMWR Morb. Mortal. Wkly. Rep. 51: 686– 688.
23.
CDC. 2000. Human rabies—California, Georgia, Minnesota, New York, and Wisconsin, 2000. MMWR Morb. Mortal. Wkly. Rep. 49: 1111– 1115.
24.
CDC. 1996. Human rabies—Florida, 1996. MMWR Morb. Mortal. Wkly. Rep. 45: 719– 720, 727.
25.
CDC. 2005. Human rabies—Florida, 2004. MMWR Morb. Mortal. Wkly. Rep. 54: 767– 768.
26.
CDC. 2007. Human rabies—Indiana and California, 2006. MMWR Morb. Mortal. Wkly. Rep. 56: 361– 365.
27.
CDC. 2003. Human rabies—Iowa, 2002. MMWR Morb. Mortal. Wkly. Rep. 52: 47– 48.
28.
CDC. 1997. Human rabies—Kentucky and Montana 1996. MMWR Morb. Mortal. Wkly. Rep. 46: 397– 400.
29.
CDC. 1983. Human rabies—Kenya. MMWR Morb. Mortal. Wkly. Rep. 32: 494– 495.
30.
CDC. 1994. Human rabies—Miami, 1994. MMWR Morb. Mortal. Wkly. Rep. 43: 773– 775.
31.
CDC. 1983. Human rabies—Michigan. MMWR Morb. Mortal. Wkly. Rep. 32: 159– 160.
32.
CDC. 1997. Human rabies—Montana and Washington, 1997. MMWR Morb. Mortal. Wkly. Rep. 46: 770– 774.
33.
CDC. 1997. Human rabies—New Hampshire, 1996. MMWR Morb. Mortal. Wkly. Rep. 46: 267– 270.
34.
CDC. 1993. Human rabies—New York, 1993. MMWR Morb. Mortal. Wkly. Rep. 42: 799, 806.
35.
CDC. 1981. Human rabies—Oklahoma. MMWR Morb. Mortal. Wkly. Rep. 30: 343– 344, 349.
36.
CDC. 1989. Human rabies—Oregon, 1989. MMWR Morb. Mortal. Wkly. Rep. 38: 335– 337.
37.
CDC. 1984. Human rabies—Pennsylvania. MMWR Morb. Mortal. Wkly. Rep. 33: 633– 635.
38.
CDC. 1982. Human rabies—Rwanda. MMWR Morb. Mortal. Wkly. Rep. 31: 135.
39.
CDC. 2002. Human rabies—Tennessee, 2002. MMWR Morb. Mortal. Wkly. Rep. 51: 828– 829.
40.
CDC. 1984. Human rabies—Texas. MMWR Morb. Mortal. Wkly. Rep. 33: 469– 470.
41.
CDC. 1994. Human rabies—Texas and California, 1993. MMWR Morb. Mortal. Wkly. Rep. 43: 93– 96.
42.
CDC. 1998. Human rabies—Texas and New Jersey, 1997. MMWR Morb. Mortal. Wkly. Rep. 47: 1– 5.
43.
CDC. 1991. Human rabies—Texas, 1990. MMWR Morb. Mortal. Wkly. Rep. 40: 132– 133.
44.
CDC. 1991. Human rabies—Texas, Arkansas, and Georgia, 1991. MMWR Morb. Mortal. Wkly. Rep. 40: 765– 769.
45.
CDC. 1999. Human rabies—Virginia, 1998. MMWR Morb. Mortal. Wkly. Rep. 48: 95– 97.
46.
CDC. 1995. Human rabies—Washington, 1995. MMWR Morb. Mortal. Wkly. Rep. 44: 625– 627.
47.
CDC. 1995. Human rabies—West Virginia, 1994. MMWR Morb. Mortal. Wkly. Rep. 44: 86– 87, 93.
48.
CDC. 1985. Human rabies acquired outside the United States. MMWR Morb. Mortal. Wkly. Rep. 34: 235– 236.
49.
CDC. 1985. Human rabies diagnosed 2 months postmortem—Texas. MMWR Morb. Mortal. Wkly. Rep. 34: 700, 705– 707.
50.
CDC. 2008. Human rabies prevention—United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recommend. Rep. 57: 1– 28.
51.
CDC. 1988. Imported dog and cat rabies—New Hampshire, California. MMWR Morb. Mortal. Wkly. Rep. 37: 559– 560.
52.
CDC. 1983. Imported human rabies. MMWR Morb. Mortal. Wkly. Rep. 32: 78– 80, 85– 86.
53.
CDC. 1995. Mass treatment of humans exposed to rabies—New Hampshire, 1994. MMWR Morb. Mortal. Wkly. Rep. 44: 484– 486.
54.
CDC. 1999. Public health response to a potentially rabid bear cub—Iowa, 1999. MMWR Morb. Mortal. Wkly. Rep. 48: 971– 973.
55.
CDC. 2008. Public health response to a rabid kitten—four states, 2007. MMWR Morb. Mortal. Wkly. Rep. 56: 1337– 1340.
56.
CDC. 2002. Rabies in a beaver—Florida, 2001. MMWR Morb. Mortal. Wkly. Rep. 51: 481– 482.
57.
CDC. 2008. Rabies in a dog imported from Iraq—New Jersey, June 2008. MMWR Morb. Mortal. Wkly. Rep. 57: 1076– 1078.
58.
CDC. 1977. Rabies in a laboratory worker—New York. MMWR Morb. Mortal. Wkly. Rep. 26: 183– 184.
59.
CDC. 2004. Recovery of a patient from clinical rabies—Wisconsin, 2004. MMWR Morb. Mortal. Wkly. Rep. 53: 1171– 1173.
60.
CDC. 1995. Translocation of coyote rabies—Florida, 1994. MMWR Morb. Mortal. Wkly. Rep. 44: 580– 581, 587.
61.
CDC. 2000. Update: raccoon rabies epizootic—United States and Canada, 1999. MMWR Morb. Mortal. Wkly. Rep. 49: 31– 35.
62.
Chang, H. G.,, M. Eidson,, C. Noonan–Toly,, C. V. Trimarchi,, R. Rudd,, B. J. Wallace,, P. F. Smith, and, D. L. Morse. 2002. Public health impact of reemergence of rabies, New York. Emerg. Infect. Dis. 8: 909– 913.
63.
Charlton, K. M.,, W. A. Webster,, G. A. Casey, and, C. E. Rupprecht. 1988. Skunk rabies. Rev. Infect. Dis. 10 (Suppl. 4): S626– S628.
64.
Childs, J. E.,, L. Colby,, J. W. Krebs,, T. Strine,, M. Feller,, D. Noah,, C. Drenzek,, J. S. Smith, and, C. E. Rupprecht. 1997. Surveillance and spatiotemporal associations of rabies in rodents and lagomorphs in the United States, 1985–1994. J. Wildl. Dis. 33: 20– 27.
65.
Cliquet, F., and, M. Aubert. 2004. Elimination of terrestrial rabies in Western European countries. Dev. Biol. (Basel) 119: 185– 204.
66.
Constantine, D. G. 1962. Rabies transmission by nonbite route. Public Health Rep. 77: 287– 289.
67.
Constantine, D. G. 1979. An updated list of rabies-infected bats in North America. J. Wildl. Dis. 15: 347– 349.
68.
Conti, L.,, S. Wiersma, and, R. Hopkins. 2002. Evaluation of state-provided postexposure prophylaxis against rabies in Florida. South. Med. J. 95: 225– 230.
69.
Dean, D.,, M. K. Abelseth, and, P. Atanasiu. 1996. The fluorescent antibody test, 4th ed. World Health Organization, Geneva, Switzerland.
70.
Devriendt, J.,, M. Staroukine,, F. Costy, and, J. J. Vanderhaeghen. 1982. Fatal encephalitis apparently due to rabies. Occurrence after treatment with human diploid cell vaccine but not rabies immune globulin. JAMA 248: 2304– 2306.
71.
Dhankhar, P.,, S. A. Vaidya,, D. B. Fishbien, and, M. I. Meltzer. 2008. Cost effectiveness of rabies post exposure prophylaxis in the United States. Vaccine 26: 4251– 4255.
72.
Dietzschold, B., and, M. J. Schnell. 2002. New approaches to the development of live attenuated rabies vaccines. Hybrid. Hybridomics 21: 129– 134.
73.
Dietzschold, M. L.,, M. Faber,, J. A. Mattis,, K. Y. Pak,, M. J. Schnell, and, B. Dietzschold. 2004. In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife. Vaccine 23: 518– 524.
74.
Eng, T. R.,, D. B. Fishbein, et al. 1990. Epidemiologic factors, clinical findings, and vaccination status of rabies in cats and dogs in the United States in 1988. J. Am. Vet. Med. Assoc. 197: 201– 209.
75.
Everard, C. O., and, J. D. Everard. 1992. Mongoose rabies in the Caribbean. Ann. N. Y. Acad. Sci. 653: 356– 366.
76.
Fekadu, M.,, T. Endeshaw,, W. Alemu,, Y. Bogale,, T. Teshager, and, J. G. Olson. 1996. Possible human-to-human transmission of rabies in Ethiopia. Ethiop. Med. J. 34: 123– 127.
77.
Fishbein, D. B.,, K. W. Bernard,, K. D. Miller,, T. Van der Vlugt,, C. E. Gains,, J. T. Bell,, J. W. Sumner,, F. L. Reid,, R. A. Parker,, J. T. Horman, et al. 1986. The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine. Am. J. Trop. Med. Hyg. 35: 663– 670.
78.
Foroutan, P.,, M. I. Meltzer, and, K. A. Smith. 2002. Cost of distributing oral raccoonvariant rabies vaccine in Ohio: 1997–2000. J. Am. Vet. Med. Assoc. 220: 27– 32.
79.
Gacouin, A.,, H. Bourhy,, J. C. Renaud,, C. Camus,, E. Suprin, and, R. Thomas. 1999. Human rabies despite postexposure vaccination. Eur. J. Clin. Microbiol. Infect. Dis. 18: 233– 235.
80.
Gomez, M. R.,, R. G. Siekert, and, E. C. Herrmann. 1965. A human case of skunk rabies. Case report with comment on virological studies and the prophylactic treatment. JAMA 194: 333– 335.
81.
Hanlon, C. A.,, I. V. Kuzmin,, J. D. Blanton,, W. C. Weldon,, J. S. Manangan, and, C. E. Rupprecht. 2005. Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res. 111: 44– 54.
82.
Hattwick, M. A.,, F. H. Hochberg,, P. J. Landrigan, and, M. B. Gregg. 1972. Skunk-associated human rabies. JAMA 222: 44– 47.
83.
Held, J. R.,, E. S. Tierkel, and, J. H. Steele. 1967. Rabies in man and animals in the United States, 1946–65. Public Health Rep. 82: 1009– 1018.
84.
Hellenbrand, W.,, C. Meyer,, G. Rasch,, I. Steffens, and, A. Ammon. 2005. Cases of rabies in Germany following organ transplantation. Euro Surveill. 10: E0502246.
85.
Helmick, C. G. 1983. The epidemiology of human rabies postexposure prophylaxis, 1980–1981. JAMA 250: 1990– 1996.
86.
Humphrey, G. L.,, G. E. Kemp, and, E. G. Wood. 1960. A fatal case of rabies in a woman bitten by an insectivorous bat. Public Health Rep. 75: 317– 326.
87.
Javadi, M. A.,, A. Fayaz,, S. A. Mirdehghan, and, B. Ainollahi. 1996. Transmission of rabies by corneal graft. Cornea 15: 431– 433.
88.
Jenkins, S. R., and, W. G. Winkler. 1987. Descriptive epidemiology from an epizootic of raccoon rabies in the Middle Atlantic states, 1982–1983. Am. J. Epidemiol. 126: 429– 437.
89.
Jones, R. D.,, L. Kelly,, A. R. Fooks, and, M. Wooldridge. 2005. Quantitative risk assessment of rabies entering Great Britain from North America via cats and dogs. Risk Anal. 25: 533– 542.
90.
Krebs, J. W.,, R. C. Holman,, U. Hines,, T. W. Strine,, E. J. Mandel, and, J. E. Childs. 1992. Rabies surveillance in the United States during 1991. J. Am. Vet. Med. Assoc. 201: 1836– 1848.
91.
Krebs, J. W.,, S. C. Long-Marin, and, J. E. Childs. 1998. Causes, costs, and estimates of rabies postexposure prophylaxis treatments in the United States. J. Public Health Manag. Pract. 4: 56– 62.
92.
Krebs, J. W.,, E. J. Mandel,, D. L. Swerdlow, and, C. E. Rupprecht. 2005. Rabies surveillance in the United States during 2004. J. Am. Vet. Med. Assoc. 227: 1912– 1925.
93.
Krebs, J. W.,, A. M. Mondul,, C. E. Rupprecht, and, J. E. Childs. 2001. Rabies surveillance in the United States during 2000. J. Am. Vet. Med. Assoc. 219: 1687– 1699.
94.
Krebs, J. W.,, H. R. Noll,, C. E. Rupprecht, and, J. E. Childs. 2002. Rabies surveillance in the United States during 2001. J. Am. Vet. Med. Assoc. 221: 1690– 1701.
95.
Leslie, M.,, S. L. Messenger,, R. E. Rohde,, J. S. Smith,, R. Cheshier,, C. A. Hanlon, and, C. E. Rupprecht. 2006. Bat-associated rabies virus in skunks. Emerg. Infect. Dis. 12: 1274– 1277.
96.
MacInnes, C. D.,, S. M. Smith,, R. R. Tinline,, N. R. Ayers,, P. Bachmann,, D. G. Ball,, L. A. Calder,, S. J. Crosgrey,, C. Fielding,, P. Hauschildt,, J. M. Honig,, D. H. Johnston,, K. F. Lawson,, C. P. Nunan,, M. A. Pedde,, B. Pond,, R. B. Stewart, and, D. R. Voigt. 2001. Elimination of rabies from red foxes in eastern Ontario. J. Wildl. Dis. 37: 119– 132.
97.
Mahendra, B. J.,, S. N. Madhusudana,, D. H. Ashwathnarayana,, G. Sampath,, S. S. Datta,, M. K. Sudarshan,, G. M. Venkatesh,, K. Muhamuda,, G. Bilagumba, and, M. Shamanna. 2007. A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine (PDEV) manufactured in India (Vaxirab) and Switzerland (Lyssavac-N): a randomized simulated post-exposure study in healthy volunteers. Vaccine 25: 8405– 8409.
98.
Mann, J. M. 1984. Routine pre-exposure rabies prophylaxis: a reassessment. Am. J. Public Health 74: 720– 722.
99.
Markotter, W.,, C. Van Eeden,, I. V. Kuzmin,, C. E. Rupprecht,, J. T. Paweska,, R. Swanepoel,, A. R. Fooks,, C. T. Sabeta,, F. Cliquet, and, L. H. Nel. 2008. Epidemiology and pathogenicity of African bat lyssaviruses. Dev. Biol. (Basel) 131: 317– 325.
100.
McQuiston, J. H.,, T. Wilson,, S. Harris,, R. M. Bacon,, S. Shapiro,, I. Trevino,, J. Sinclair,, G. Galland, and, N. Marano. 2008. Importation of dogs into the United States: risks from rabies and other zoonotic diseases. Zoonoses Public Health 55: 421– 426.
101.
McQuiston, J. H.,, P. A. Yager,, J. S. Smith, and, C. E. Rupprecht. 2001. Epidemiologic characteristics of rabies virus variants in dogs and cats in the United States, 1999. J. Am. Vet. Med. Assoc. 218: 1939– 1942.
102.
Meltzer, M. I., and, C. E. Rupprecht. 1998. A review of the economics of the prevention and control of rabies. Part 2. Rabies in dogs, livestock and wildlife. Pharmacoeconomics 14: 481– 498.
103.
Moore, D. A.,, W. M. Sischo,, A. Hunter, and, T. Miles. 2000. Animal bite epidemiology and surveillance for rabies postexposure prophylaxis. J. Am. Vet. Med. Assoc. 217: 190– 194.
104.
Noah, D. L.,, C. L. Drenzek,, J. S. Smith,, J. W. Krebs,, L. Orciari,, J. Shaddock,, D. Sanderlin,, S. Whitfield,, M. Fekadu,, J. G. Olson,, C. E. Rupprecht, and, J. E. Childs. 1998. Epidemiology of human rabies in the United States, 1980 to 1996. Ann. Intern. Med. 128: 922– 930.
105.
O’Bell, S. A.,, J. McQuiston,, L. J. Bell,, S. C. Ferguson, and, L. A. Williams. 2006. Human rabies exposures and postexposure prophylaxis in South Carolina, 1993–2002. Public Health Rep. 121: 197– 202.
106.
Phanuphak, P.,, P. Khawplod,, S. Sirivichayakul,, W. Siriprasomsub,, S. Ubol, and, M. Thaweepathomwat. 1987. Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine. Asian Pac. J. Allergy Immunol. 5: 33– 37.
107.
Robbins, A.,, M. Eidson,, M. Keegan,, D. Sackett, and, B. Laniewicz. 2005. Bat incidents at children’s camps, New York State, 1998–2002. Emerg. Infect. Dis. 11: 302– 305.
108.
Rosatte, R.,, D. Donovan,, M. Allan,, L. A. Howes,, A. Silver,, K. Bennett,, C. MacInnes,, C. Davies,, A. Wandeler, and, B. Radford. 2001. Emergency response to raccoon rabies introduction into Ontario. J. Wildl. Dis. 37: 265– 279.
109.
Rupprecht, C. E.,, A. N. Hamir,, D. H. Johnston, and, H. Koprowski. 1988. Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). Rev. Infect. Dis. 10 (Suppl. 4): S803– S809.
110.
Sidwa, T. J.,, P. J. Wilson,, G. M. Moore,, E. H. Oertli,, B. N. Hicks,, R. E. Rohde, and, D. H. Johnston. 2005. Evaluation of oral rabies vaccination programs for control of rabies epizootics in coyotes and gray foxes: 1995–2003. J. Am. Vet. Med. Assoc. 227: 785– 792.
111.
Slate, D.,, C. E. Rupprecht,, J. A. Rooney,, D. Donovan,, D. H. Lein, and, R. B. Chipman. 2005. Status of oral rabies vaccination in wild carnivores in the United States. Virus Res. 111: 68– 76.
112.
Smith, J. S. 1989. Rabies virus epitopic variation: use in ecologic studies. Adv. Virus Res. 36: 215– 253.
113.
Smith, J. S.,, D. B. Fishbein,, C. E. Rupprecht, and, K. Clark. 1991. Unexplained rabies in three immigrants in the United States. A virologic investigation. N. Engl. J. Med. 324: 205– 211.
114.
Smith, J. S.,, L. Orciari, and, P. Yager. 1995. Molecular epidemiology of rabies in the United States. Semin. Virol. 6: 387– 400.
115.
Smith, J. S.,, L. A. Orciari,, P. A. Yager,, H. D. Seidel, and, C. K. Warner. 1992. Epidemiologic and historical relationships among 87 rabies virus isolates as determined by limited sequence analysis. J. Infect. Dis. 166: 296– 307.
116.
Srinivasan, A.,, E. C. Burton,, M. J. Kuehnert,, C. Rupprecht,, W. L. Sutker,, T. G. Ksiazek,, C. D. Paddock,, J. Guarner,, W. J. Shieh,, C. Goldsmith,, C. A. Hanlon,, J. Zoretic,, B. Fischbach,, M. Niezgoda,, W. H. El-Feky,, L. Orciari,, E. Q. Sanchez,, A. Likos,, G. B. Klintmalm,, D. Cardo,, J. LeDuc,, M. E. Chamberland,, D. B. Jernigan, and, S. R. Zaki. 2005. Transmission of rabies virus from an organ donor to four transplant recipients. N. Engl. J. Med. 352: 1103– 1111.
117.
Stantic-Pavlinic, M. 2005. Public health concerns in bat rabies across Europe. Euro Surveill. 10: 217– 220.
118.
Tantawichien, T.,, W. Jaijaroensup,, P. Khawplod, and, V. Sitprija. 2001. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4 + T lymphocyte counts. Clin. Infect. Dis. 33: E122– E124.
119.
Tordo, N.,, A. Foumier,, C. Jallet,, M. Szelechowski,, B. Klonjkowski, and, M. Eloit. 2008. Canine adenovirus based rabies vaccines. Dev. Biol. (Basel) 131: 467– 476.
120.
Uhaa, I. J.,, V. M. Dato,, F. E. Sorhage,, J. W. Beckley,, D. E. Roscoe,, R. D. Gorsky, and, D. B. Fishbein. 1992. Benefits and costs of using an orally absorbed vaccine to control rabies in raccoons. J. Am. Vet. Med. Assoc. 201: 1873– 1882.
121.
Uhaa, I. J.,, E. J. Mandel,, R. Whiteway, and, D. B. Fishbein. 1992. Rabies surveillance in the United States during 1990. J. Am. Vet. Med. Assoc. 200: 920– 929.
122.
Velasco-Villa, A.,, L. A. Orciari,, V. Souza,, V. Juarez-Islas,, M. Gomez-Sierra,, A. Castillo,, A. Flisser, and, C. E. Rupprecht. 2005. Molecular epizootiology of rabies associated with terrestrial carnivores in Mexico. Virus Res. 111: 13– 27.
123.
Wandeler, A. I.,, S. Capt,, A. Kappeler, and, R. Hauser. 1988. Oral immunization of wildlife against rabies: concept and first field experiments. Rev. Infect. Dis. 10 (Suppl. 4): S649– S653.
124.
WHO. 2005. WHO expert consultation on rabies. First report, p. 121. WHO Tech. Rep. Ser. 931. WHO, Geneva, Switzerland.
125.
Wilde, H.,, S. Sirikawin,, A. Sabcharoen,, D. Kingnate,, T. Tantawichien,, P. A. Harischandra,, N. Chaiyabutr,, D. G. de Silva,, L. Fernando,, J. B. Liyanage, and, V. Sitprija. 1996. Failure of postexposure treatment of rabies in children. Clin. Infect. Dis. 22: 228– 232.
126.
Willoughby, R. E., Jr.,, K. S. Tieves,, G. M. Hoffman,, N. S. Ghanayem,, C. M. Amlie-Lefond,, M. J. Schwabe,, M. J. Chusid, and, C. E. Rupprecht. 2005. Survival after treatment of rabies with induction of coma. N. Engl. J. Med. 352: 2508– 2514.
127.
Wyatt, J. D.,, W. H. Barker,, N. M. Bennett, and, C. A. Hanlon. 1999. Human rabies postexposure prophylaxis during a raccoon rabies epizootic in New York, 1993 and 1994. Emerg. Infect. Dis. 5: 415– 423.
Tables
Closed Due to Rabies
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815950.ch10-1,webId=/content/author/10.1128/9781555815950.ch10-1,properties={foaf_givenname=Jesse D., foaf_name=Jesse D. Blanton, foaf_surname=Blanton, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815950.ch10-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815950.ch10-2,webId=/content/author/10.1128/9781555815950.ch10-2,properties={foaf_givenname=John W., foaf_name=John W. Krebs, foaf_surname=Krebs, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815950.ch10-aff2]]}]]
Citation:
Blanton J, Krebs J.
2009.
Closed Due to Rabies,
p 251-273.
In
Schlossberg D (ed),
Infections of Leisure, Fourth Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815950.ch10
/content/10.1128/9781555815950.ch10.ch10tab01
TABLE 1
Rabies in animals and humans in the United States (including Puerto Rico) from 2002 to 2007
TABLE 1
Rabies in animals and humans in the United States (including Puerto Rico) from 2002 to 2007
Citation:
Blanton J, Krebs J.
2009.
Closed Due to Rabies,
p 251-273.
In
Schlossberg D (ed),
Infections of Leisure, Fourth Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815950.ch10
/content/10.1128/9781555815950.ch10.ch10tab02
TABLE 2
Locations and presumed animal sources of human rabies in the United States from 1980 to 2008
TABLE 2
Locations and presumed animal sources of human rabies in the United States from 1980 to 2008
Citation:
Blanton J, Krebs J.
2009.
Closed Due to Rabies,
p 251-273.
In
Schlossberg D (ed),
Infections of Leisure, Fourth Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815950.ch10